机构：[1]Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai, China[2]Zhongshan Hospital Fudan University, Shanghai, China[3]Department of Intensive Care Unit, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China[4]Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Beijing, China临床科室心脏外科危重症中心首都医科大学附属安贞医院[5]Department of Cardiac Surgery, Huai’an First People’s Hospital, The Affiliated Huai’an No. 1 People’s Hospital of Nanjing Medical University, Huai’an, China
The impact of continuous beta-blocker (BB) therapy on structural valve deterioration (SVD) after bioprosthetic mitral replacement was investigated. From 2000 to 2005, 138 such patients were propensity score matched in a 1:1 fashion (continuous BB therapy after surgery, n = 69; without BB therapy, n = 69). Median follow-up was 12.3 years. Cardiac mortality was comparable between patients with and without BB therapy (p = 0.13), while the 10-year freedom from SVD was significantly higher in patients with BB therapy (92.4 vs. 76.3%, p = 0.001). In conclusion, continuous BB therapy may be considered in patients after bioprosthetic mitral valve replacement to delay SVD and improve prosthetic durability.
Georg Thieme Verlag KG Stuttgart · New York.
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2018]版：
大类|4 区医学
小类|4 区心脏和心血管系统4 区呼吸系统4 区外科
最新[2023]版：
大类|4 区医学
小类|4 区心脏和心血管系统4 区呼吸系统4 区外科
第一作者：
第一作者机构：[1]Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai, China[2]Zhongshan Hospital Fudan University, Shanghai, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai, China[5]Department of Cardiac Surgery, Huai’an First People’s Hospital, The Affiliated Huai’an No. 1 People’s Hospital of Nanjing Medical University, Huai’an, China[*1]Department of Cardiac Surgery, Huai’an First People’s Hospital, The Affiliated Huai’an No. 1 People’s Hospital of Nanjing Medical University, No. 1 West Huanghe Road, Huai’an 223300, China
推荐引用方式(GB/T 7714)：
Ma Wenrui,Tan Yan,Shi Qiuxia,et al.Continuous Beta-Blocker Therapy Delays Structural Deterioration after Bioprosthetic Mitral Valve Replacement.[J].THORACIC AND CARDIOVASCULAR SURGEON.2019,67(7):554-556.doi:10.1055/s-0039-1692651.
APA：
Ma Wenrui,Tan Yan,Shi Qiuxia&Xu Zhiwei.(2019).Continuous Beta-Blocker Therapy Delays Structural Deterioration after Bioprosthetic Mitral Valve Replacement..THORACIC AND CARDIOVASCULAR SURGEON,67,(7)
MLA：
Ma Wenrui,et al."Continuous Beta-Blocker Therapy Delays Structural Deterioration after Bioprosthetic Mitral Valve Replacement.".THORACIC AND CARDIOVASCULAR SURGEON 67..7(2019):554-556
